UBAZF yields 18.10% · PFE yields 6.13%● Live data
📍 UBAZF pulled ahead of the other in Year 1
Combined, UBAZF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UBAZF + PFE for your $10,000?
Uzabase, Inc. provides information infrastructure to support decision-making in business activities primarily in Japan and internationally. It operates SPEEDA, a business information platform that provides insights for business strategy development and market analysis, including global corporate data, industry reports, market data, M&A deals, and expert insights to financial institutions and general businesses; FORCAS, a B2B marketing platform; and NewsPicks, a social business media that offers economic and business news articles. The company also operates INITIAL, a startup information platform that provides one-stop source to general data, financing, investors, and business partners of startups, as well as articles on related topics; and AlphaDrive, a consulting business that supports corporate clients in relation to new business development, next generation human resource development, and revitalising organizations. In addition, it operates MIMIR, a network business; SPEEDA EDGE, a market intelligent platform that offers industry-driven insights, including emerging tech trends, disruptors, partnership deals, and custom research; and UB VENTURES, a venture capital business that focuses on financing seed to early-stage SaaS and media startups. Uzabase, Inc. was incorporated in 2008 and is headquartered in Tokyo, Japan.
Full UBAZF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.